Indirect Treatment Comparison of Ustekinumab versus Other Biologics in Moderate‐to‐Severe Crohn's Disease Patients Having Failed Conventional Therapy: A 1‐Year Treatment Sequence Analysis Including Delayed Responders: 709. (October 2017) - Mesana, Laura; Pacou, Maud; Naessens, Dominik; Sloan, Sheldon; Gauthier, Aline